BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed Jun 3, 2021
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Purchase
Common Stock
2021-06-03$5.96/sh+5,000$29,800→ 1,030,000 total
Holdings
- 24,940(indirect: By LLC)
Common Stock